CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pre-Procedural Medications for Endoscopic Retrograde Cholangiopancreatography: Clinical Effectiveness and Guidelines

Last updated: July 8, 2020
Project Number: RA1125-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical effectiveness of pre-procedural medications for endoscopic retrograde cholangiopancreatography?
  2. What are the guidelines for pre-procedural medications for endoscopic retrograde cholangiopancreatography?

Key Message

Two systematic reviews with meta-analyses, four randomized controlled trials, three non-randomized studies, and six evidence-based guidelines were identified regarding the clinical effectiveness or use of pre-procedural medications for endoscopic retrograde cholangiopancreatography.